Psychophysiological Effects of Lactobacillus Plantarum PS128 in Patients With Major Depressive Disorder and High Level of Inflammation: a Pilot Study of 8-week Open Trial
试验速览
- 阶段
- 不适用
- 入组人数
- 40
- 试验地点
- 1
- 主要终点
- Changes of serum hs-CRP
研究概览
简要总结
Recent studies have suggested that gut-brain axis may be one of the mechanisms of major depression disorder (MDD). In animal studies, alteration of gut microbiota can affect animal's depression or anxiety-like behavior, brain neurochemistry and inflammation. In human studies, the composition of gut microbiota is different between patients with MDD and healthy controls. In addition, supplementation of probiotics can improve mood status in community and clinical participants. Inflammation is one of possible pathway to connect gut and brain. Gut permeability and inflammation level are higher in patients with MDD. Lactobacillus plantarum PS128 in one of bacteria extracted from traditional fermented food, Fu-Tsai. It can alleviate depressive-like behavior reduce inflammation level in maternal separation mice. This study is an 8-week open trial to investigate the effects of Lactobacillus plantarum PS128 on psychophysiology in patients with MDD and higher level of inflammation.
This is a two-phase study. In the first phase, we will recruited patients fulfilling the following inclusion criteria: Age 20-65; fulfill Diagnostic and Statistical Manual of Mental Disorders fifth version (DSM-V) criteria of major depressive episode in recent 2 years; Psychotropics including antidepressants, antipsychotics and hypnotics have been kept unchanged for at least 3 months. The exclusion criteria are: comorbid with schizophrenia, bipolar disorder, or other substance use (except tobacco) disorder; having active suicidal or homicidal ideation; known allergy to probiotics; comorbid with hypertension, diabetes mellitus, irritable bowel syndrome, inflammatory bowl disease, liver cirrhosis, or autoimmune diseases; known active bacterial, fungal, or viral infections in one month; use of antibiotics, steroid, immunosuppressants, probiotics, or synbiotics in the month before collecting blood and fecal samples; pregnant or lactating women; who state to have dietary pattern changed or in diet within previous two months. Those hs-CRP > 3 mg/L in the first screen will be invited into the second phase intervention. In the second phase intervention, we will give eligible patients Lactobacillus plantarum PS128 for 8 weeks, and compare depression symptoms, gut microbiota, gut inflammation and permeability, and serum inflammation level before and after intervention.
详细描述
- Background Major depressive disorder (MDD) is a complex and long-term illness that involves marked disabilities in affected patients. It has been one of the leading causes of global burden of disease, especially in the middle-age groups (GBD Lancet 2016; 388:1603-58). It is also a common comorbidity in patients with irritable bowel syndrome, cardiovascular disease and cancer (Musselman et al. 1998; Spiegel et al. 2003; Whitehead et al. 2002). The mechanisms responsible for depression and its comorbidity are not clear, but inflammatory processes may be implicated. Meta-analysis has shown that patients with depression have higher levels of inflammatory markers, such as C-Reactive Protein (CRP), interleukin-1 (IL-1), interleukin-6 (IL-6), and tumor necrosis factor (TNF)-alpha (Dowlati et al. 2010; Howren et al. 2009). Microbiota-gut-brain axis may explain higher inflammatory cytokines in patients with MDD. Accumulating data now indicate that the gut microbiota can communicate with the CNS--possibly through immune, neural, and endocrine pathways--and thereby influences brain function and behavior (Cryan et al. 2012; Forsythe et al. 2016; Rogers et al. 2016). Probiotics, which are defined as a live organism that when ingested in adequate amount exerts a health benefit, can affect gut microbiota, brain neurochemistry, HPA axis, and inflammation, and may be a novel class of psychotropics (Dinan et al. 2013).
1.1 Microbiota-gut-brain axis The lower gastrointestinal tract contains almost 100 trillion microorganisms, most of which are bacteria. The microbiota collectively encodes more than 3.3 million non-redundant genes, exceeding the number encoded by the human host genome by 150-fold (Qin et al. 2010). Many microbial gene products have important effects on metabolism and the health of the host.
There have been numerous studies supporting the communications between gut microbiota and brain. Study using germ free (GF) animal is a good model to show the relationship between microbiota and brain. Compared to specific pathogen free (SPF) mice with a normal gut microbiota, GF mice display increased motor activity and reduced anxiety behavior. An increased turnover of dopaminergic and serotonergic neurotransmitters in striatum was observed in GF mice (Diaz Heijtz et al. 2011). In addition, GF mice exhibited higher adrenocorticotropic hormone (ACTH) and corticosterone elevation in response to restraint stimulus than SPF mice did (Sudo et al. 2004). It suggests that gut microbiota can affect host's response to stress.
Several studies have shown that manipulation of gut microbiota can affect the presentation of host's psychophysiology. For example, consumption of high fat diet (HFD) is associated with altered microbial diversity (Daniel et al. 2014) and reduced synaptic plasticity (Liu et al. 2015). HFD also increased anxiety-like behavior (Sharma et al. 2013). Adult male C57BL/6 mice given HFD microbiota had significant and selective disruptions in exploratory, cognitive, and stereotypical behavior compared with mice with control diet microbiota. No significant differences in body weight were noted. The difference in composition of gut microbiota between HFD and normal-diet groups was noted (Bruce-Keller et al. 2015).
Administration of antibiotics is another way to affect gut microbiota composition and change host's psychophysiology. Oral administration of non-absorbable antimicrobials transiently altered gut microbiota composition and increased exploratory behavior and hippocampal expression of BDNF mRNA in mice, but intraperitoneal administration had no effect on behavior (Bercik et al. 2011). Increased antibiotic exposures were associated with the risk of depression and anxiety in a population study (Lurie et al. 2015). Therefore, administration of probiotics may be a direct way to change the environment and composition of gut microbiota, and observe its physiological effects on host.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 20 Years 至 65 Years(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •fulfill Diagnostic and Statistical Manual of Mental Disorders fifth version (DSM-V) criteria of major depressive episode in recent 2 years
- •Psychotropics including antidepressants, antipsychotics and hypnotics have been kept unchanged for at least 3 months
- •hs-CRP > 3 mg/L
- •HAMD-17 < 14
排除标准
- •Comorbid with schizophrenia, bipolar disorder, or other substance use (except tobacco) disorder.
- •having active suicidal or homicidal ideation
- •known allergy to probiotics
- •comorbid with hypertension, diabetes mellitus, irritable bowel syndrome, inflammatory bowl disease, liver cirrhosis, or autoimmune diseases
- •known active bacterial, fungal, or viral infections in one month.
- •use of antibiotics, steroid, immunosuppressants, probiotics, or synbiotics in the month before collecting blood and fecal samples
- •pregnant or lactating women
- •who obviously change dietary pattern or in diet within previous two months
研究组 & 干预措施
Lactobacillus plantarum PS128
Each PS 128 capsule contains 300 mg of probiotics. PS128 will be provided 300 mg twice, in the morning and in the afternoon, daily.
干预措施: Lactobacillus plantarum PS128 (Dietary Supplement)
结局指标
主要结局
Changes of serum hs-CRP
时间窗: baseline, week 4 and week 8
measure serum hs-CRP at baseline, week 4 and week8
Changes of serum TNF-alpha
时间窗: baseline, week 4 and week 8
measure serum TNF-alpha at baseline, week 4 and week8
Changes of serum IL-6
时间窗: baseline, week 4 and week 8
measure serum IL-6 at baseline, week 4 and week8
Changes of serum IL-10
时间窗: baseline, week 4 and week 8
measure serum IL-10 at baseline, week 4 and week8
次要结局
- Change of calprotectin(baseline and week 8)
- Changes of expression of Toll-like proteins(baseline and week 8)
- Changes of HAMD-17(baseline, week 2, week 4 and week 8)
- Changes of DSSS(baseline, week 2, week 4 and week 8)
- Change of Microbiota(baseline and week 8)
- Change of zonulin(baseline and week 8)
研究者
Chun-Hsin Chen
Attending Psychiatrist
Taipei Medical University WanFang Hospital
